8 Results for "

pseudo-irreversible

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "pseudo-irreversible" in MCE Product Catalog:

12
12 Cited Publications
Cat. No.: HY-101564
CAS No.: 2086772-26-9
Purity:  99.78%
Synonyms: JNJ-64619178
Research Areas:  

Cancer

Onametostat (JNJ-64619178) is a selective, orally active and pseudo-irreversible protein arginine methyltransferase 5 (PRMT5) inhibitor with an IC50 of 0.14 nM. Onametostat has potent activity in lung cancer .
loading...
    loading...
Cat. No.: HY-120423
CAS No.: 1245626-00-9
Purity:  99.85%
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease

AM6538 is a long-acting, high affinity and pseudo-irreversible cannabinoid (CB) antagonist. AM6538 is a structural analog of rimonabant. AM6538 can be effectively used to evaluate the apparent efficacy of cannabinoid full and partial agonists. AM6538 may be useful in future studies that require temporary reductions in cannabinoid receptor availability . AM-6538 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-158417
CAS No.: 1807873-14-8
Target:  

LPL Receptor

Research Areas:  

Inflammation/Immunology

KSI-6666 is an orally active, competitive antagonist for sphingosine 1-phosphate receptor 1 (S1PR1), with an IC50 of 6.4 nM. KSI-6666 exhibits anti-inflammatory efficacy in autoimmune encephalomyelitis model and T cell transfer colitis model .
loading...
    loading...
Cat. No.: HY-135698
CAS No.: 117339-76-1
Synonyms: M-CAM
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Methocinnamox (M-CAM) a selective and long-acting μ-opioid receptor (MOR) antagonist with a Ki of 0.6 nM. Methocinnamox binds to the orthosteric site of the MOR in a pseudo-irreversible, non-covalent manner, resulting in prolonged receptor blockade that persists until new receptors are synthesized. Methocinnamox acts as a reversible antagonist at both the kappa-opioid receptor (KOR) (Ki = 4.9 nM) and delta-opioid receptor (DOR) (Ki = 2.2 nM), and it exhibits no intrinsic agonist activity at these receptors. Methocinnamox can be used to reverse and prevent opioid overdose and addiction .
loading...
    loading...
Cat. No.: HY-152232
CAS No.: 3060336-91-3
Target:  

Cholinesterase (ChE)

Research Areas:  

Cancer

BChE-IN-15 (Compound 6) is a pseudo-irreversible and covalent BChE inhibitor with an IC50 of 1.76 nM against hBChE .
loading...
    loading...
Cat. No.: HY-144689
CAS No.: 3033413-58-7
Target:  

Cholinesterase (ChE)

Research Areas:  

Neurological Disease

BChE-IN-3 (compound 45a) is a potent, selective, time-dependent and pseudoirreversible BChE inhibitor, with an IC50 of 56.9 nM. BChE-IN-3 also shows marginal and reversible (not time-dependent) inhibition of AChE .
loading...
    loading...
Cat. No.: HY-101564R
CAS No.: 2086772-26-9
Synonyms: JNJ-64619178 (Standard)
Research Areas:  

Cancer

Onametostat (Standard) is the analytical standard of Onametostat (HY-101564). This product is intended for research and analytical applications. Onametostat (JNJ-64619178) is a selective, orally active and pseudo-irreversible protein arginine methyltransferase 5 (PRMT5) inhibitor with an IC50 of 0.14 nM. Onametostat has potent activity in lung cancer .
loading...
    loading...
Cat. No.: HY-181865
BuChE-IN-22 is a pseudo-irreversible butyrylcholinesterase (BuChE) inhibitor, with IC50 values of 4 nM and 157 nM against hBuChE and hAChE, respectively. It also acts as a prodrug of 7-hydroxysertraline. BuChE-IN-22 releases 7-hydroxysertraline during BuChE inhibition. BuChE-IN-22 completely reverses Aβ25-35-induced short-term and long-term memory impairments in a mouse model of Alzheimer's disease. BuChE-IN-22 can be used in research related to Alzheimer's disease .
loading...
    loading...